Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: Evidence-based predictors

Kardiologia Polska

Volumn 67, Issue 8, 2009, Pages 837-844

  Dułak, Elzbieta ^a   Lubiński, Andrzej ^b   Bissinger, Andrzej ^b   Przybylski, Andrzej ^c   Sterlinski, Maciej ^c   Filipecki, Artur ^d   Pazdyga, Anna ^e   Zienciuk, Agnieszka ^e   Kempa, Maciej ^e   Królak, Tomasz ^e   Szwed, Hanna ^c   Trusz Gluza, Maria ^d   Kargul, Włodzimierz ^d  

^a J Brudzi ski Hospital   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c INSTITUTE OF CARDIOLOGY   (Poland)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

^e MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Arrhythmia; Cardiomyopathy; Implantable cardioverter defibrillator; Risk factors; Sudden death

Indexed keywords

AMIODARONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOTALOL; SPIRONOLACTONE;

ADULT; AGED; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; DIURETIC THERAPY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; RISK FACTOR; STATISTICAL ANALYSIS; SUDDEN DEATH;

EID: 72549108603     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816
2. Gillum RF. Idiopathic cardiomyopathy in the United States, 1970-1982. Am Heart J 1986; 111: 752-755
3. Di Lenarda A, Pinamonti B, Mestroni L, et al. The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste. Ital Heart J Suppl 2004; 5: 253-266
4. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 1987; 60: 1340-1355
5. Dubner S, Valero E, Pesce R, et al. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study. Ann Noninvasive Electrocardiol 2005; 10: 420-428 (Pubitemid 43942701)
6. Fruhwald FM, Dusleag J, Eber B, et al. Long-term outcome and prognostic factors in dilated cardiomyopathy. Preliminary results. Angiology 1994; 45: 763-770
7. Hsia HH, Marchlinski FE. Electrophysiology studies in patients with dilated cardiomyopathies. Card Electrophysiol Rev 2002; 6: 472-481
8. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746-837.
9. Fazio G, Veltri EP, Tomaselli G, et al. Long-term follow-up of patients with nonischemic dilated cardiomyopathy and ventricular tachyarrhythmias treated with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1991; 14: 1905-1910
10. Coughlin SS, Tefft MC, Rice JC, et al. Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies. Am J Epidemiol 1996; 143: 881-888
11. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564-1575
12. Estruch R, Fernandez-Sola J, Sacanella E, et al. Relationship between cardiomyopathy and liver disease in chronic alcoholism. Hepatology 1995; 22: 532-538
13. Faris RF, Henein MY, Coats AJ. Influence of gender and reported alcohol intake on mortality in nonischemic dilated cardiomyopathy. Heart Dis 2003; 5: 89-94.
14. Greenspon AJ, Schaal SF. The 'holiday heart': electrophysiologic studies of alcohol effects in alcoholics. Ann Intern Med 1983; 98: 135-139
15. Rosenqvist M. Alcohol and cardiac arrhythmias. Alcohol Clin Exp Res 1998; 22: 318S-22.
16. Knight BP, Goyal R, Pelosi F, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33: 1964-1970
17. Sun JP, James KB, Yang XS, et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. Am J Cardiol 1997; 80: 1583-1587
18. Mehta D, Saksena S, Krol RB. Survival of implantable cardioverter- defibrillator recipients: role of left ventricular function and its relationship to device use. Am Heart J 1992; 124: 1608-1614 (Pubitemid 23003599)
19. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453-1458 (Pubitemid 34263277)
20. Borggrefe M, Chen X, Martinez-Rubio A, et al. The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Am Heart J 1994; 127: 1145-1150 (Pubitemid 124006922)
21. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 1993; 342: 821-828 (Pubitemid 23285909)
22. Køber L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995; 333: 1670-1676
23. Domanski MJ, Exner DV, Borkowf CB, et al. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 1999; 33: 598-604.
24. Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100: 1311-1315 (Pubitemid 29440124)
25. Doval HC, Nul DR, Grancelli HO, et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994; 344: 493-498 (Pubitemid 24261565)
26. Dickinson MG, Ip JH, Olshansky B, et al. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007; 153: 573-578 (Pubitemid 46440697)
27. Goldberger JJ, Subacius H, Schaechter A, et al. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1228-1233 (Pubitemid 44363151)
28. De Sutter J, Tavernier R, De Buyzere M, et al. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 2000; 36: 766-772 (Pubitemid 30681596)
29. Mitchell LB, Powell JL, Gillis AM, et al. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol 2003; 42: 81-87 (Pubitemid 36760765)
30. Vyas AK, Guo H, Moss AJ, et al. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006; 47: 769-773 (Pubitemid 43243099)
31. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707-1712
32. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237 (Pubitemid 40110811)